Pykus Therapeutics Inc.
PrivateLast Round
Grant
Mar 1, 2023
Total Funding Raised
$2.64M
Company Overview
Pykus Therapeutics Inc. operates in Healthcare & Life Sciences and is based in Cambridge, Massachusetts. Its latest recorded funding round was a Grant round in March 2023.
Pykus Therapeutics Inc. is a clinical-stage medical technology company developing biodegradable polymers to provide solutions for unmet needs in vitreoretinal surgery.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pykus Therapeutics Inc. Comparables
Compare Pykus Therapeutics Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Geuder AG | 71% | |
| Bausch + Lomb Corporation | 70% | |
| BVI Medical | 65% |
For institutional investors. Book with your work email.
Pykus Therapeutics Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 1, 2023 | ||||
| Seed | Feb 4, 2021 | ||||
| Grant | Nov 2, 2017 | ||||
| Grant | May 4, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Pykus Therapeutics Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SideCar Angels | Seed |
| Bertarelli Foundation | Grant |
| Beacon Angels | Seed |
| Mass General Brigham Innovation | Seed |
| MassChallenge Israel | Grant |
| Astellas Venture Management | Seed |
| ShangBay Capital | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 10, 2025
Initial data on novel retinal sealant PYK-2101 to be presented at Vail Vitrectomy 2025.
- Feb 10, 2025
Will present at the Vail Vitrectomy 2025 Meeting.
For institutional investors. Book with your work email.
Pykus Therapeutics Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Pykus Therapeutics Inc.'s valuation, stock price, and market status.
Is Pykus Therapeutics Inc. a public or private company?
Pykus Therapeutics Inc. is a private company.
What is the current stock price of Pykus Therapeutics Inc.?
Pykus Therapeutics Inc. is a private company, so its shares have no public market price. Caplight tracks Pykus Therapeutics Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Pykus Therapeutics Inc. worth (valuation)?
Valuation information for Pykus Therapeutics Inc. is not publicly available.
Can I buy Pykus Therapeutics Inc. stock?
Pykus Therapeutics Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Pykus Therapeutics Inc.'s last funding round?
Pykus Therapeutics Inc.'s most recent funding round was Grant on March 1, 2023.
Who are the main investors in Pykus Therapeutics Inc.?
Key investors in Pykus Therapeutics Inc. include SideCar Angels, Bertarelli Foundation, Beacon Angels, Mass General Brigham Innovation, MassChallenge Israel.
Will Pykus Therapeutics Inc. IPO soon?
No public IPO plans have been announced for Pykus Therapeutics Inc..
How can I track Pykus Therapeutics Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Pykus Therapeutics Inc.'s shares on secondary markets.